| Critical factors in the release of drugs from sustained release hydrophilic matrices C Maderuelo, A Zarzuelo, JM Lanao Journal of controlled release 154 (1), 2-19, 2011 | 697 | 2011 |
| Pharmacokinetics of amikacin in intensive care unit patients MMF de Gatta, ME Mendez, S Romano, MV Calvo, A Dominguez‐Gil, ... Journal of clinical pharmacy and therapeutics 21 (6), 417-421, 1996 | 567 | 1996 |
| Current applications of nanoparticles in infectious diseases H Zazo, CI Colino, JM Lanao Journal of Controlled Release 224, 86-102, 2016 | 442 | 2016 |
| Drug, enzyme and peptide delivery using erythrocytes as carriers CG Millan, MLS Marinero, AZ Castaneda, JM Lanao Journal of controlled release 95 (1), 27-49, 2004 | 283 | 2004 |
| Delivery systems to increase the selectivity of antibiotics in phagocytic cells E Briones, CI Colino, JM Lanao Journal of Controlled Release 125 (3), 210-227, 2008 | 261 | 2008 |
| Targeting of hepatic macrophages by therapeutic nanoparticles CI Colino, JM Lanao, C Gutierrez-Millan Frontiers in immunology 11, 218, 2020 | 111 | 2020 |
| Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability C Maderuelo, JM Lanao, A Zarzuelo European Journal of Pharmaceutical Sciences 138, 105019, 2019 | 110 | 2019 |
| High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues L Álvarez-Cedrón, ML Sayalero, JM Lanao Journal of Chromatography B: Biomedical Sciences and Applications 721 (2 …, 1999 | 109 | 1999 |
| International seminar on the red blood cells as vehicles for drugs Y Godfrin, F Horand, R Franco, E Dufour, E Kosenko, BE Bax, A Banz, ... Expert opinion on biological therapy 12 (1), 127-133, 2012 | 102 | 2012 |
| Recent advances in colon drug delivery systems R Arévalo-Pérez, C Maderuelo, JM Lanao Journal of Controlled Release 327, 703-724, 2020 | 101 | 2020 |
| Population pharmacokinetics of amikacin in patients with haematological malignancies S Romano, MMF De Gatta, MV Calvo, D Caballero, A Dominguez-Gil, ... Journal of Antimicrobial Chemotherapy 44 (2), 235-242, 1999 | 95 | 1999 |
| Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis CG Millán, AZ Castañeda, MLS Marinero, JM Lanao Blood Cells, Molecules, and Diseases 33 (2), 132-140, 2004 | 82 | 2004 |
| Drug-loaded erythrocytes: on the road toward marketing approval V Bourgeaux, JM Lanao, BE Bax, Y Godfrin Drug design, development and therapy, 665-676, 2016 | 78 | 2016 |
| Cell-based drug-delivery platforms C Gutiérrez Millán, CI Colino Gandarillas, ML Sayalero Marinero, ... Therapeutic delivery 3 (1), 25-41, 2012 | 73 | 2012 |
| Advances in exosomes‐based drug delivery systems C Gutierrez‐Millan, C Calvo Díaz, JM Lanao, CI Colino Macromolecular Bioscience 21 (1), 2000269, 2021 | 69 | 2021 |
| Recent advances in delivery systems for anti-HIV1 therapy JM Lanao, E Briones, CI Colino Journal of drug targeting 15 (1), 21-36, 2007 | 69 | 2007 |
| Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates JM Lanao, MV Calvo, JA Mesa, A Martín-Suárez, MT Carbajosa, ... Journal of Antimicrobial Chemotherapy 54 (1), 193-198, 2004 | 64 | 2004 |
| Recent advances in functionalized nanomaterials for the diagnosis and treatment of bacterial infections CI Colino, JM Lanao, C Gutierrez-Millan Materials Science and Engineering: C 121, 111843, 2021 | 63 | 2021 |
| Population pharmacokinetics of caffeine in premature neonates AC Falcao, MMF de Gatta, MFD Iribarnegaray, DS Buelga, MJ García, ... European journal of clinical pharmacology 52, 211-217, 1997 | 59 | 1997 |
| Nanoparticles for signaling in biodiagnosis and treatment of infectious diseases CI Colino, CG Millán, JM Lanao International journal of molecular sciences 19 (6), 1627, 2018 | 55 | 2018 |
